Sourcing Disclosure: Licensed Bangladesh Global Sourcing Specialist facilitating global access under Named Patient Regulations.
Expert-reviewed clinical data for prescription-only medicine.
Guide to Resmetirom 80 mg Cost Without Insurance
A diagnosis of MASH (metabolic dysfunction-associated steatohepatitis) brings enough stress on its own. High out-of-pocket healthcare costs should not add to that burden.
The FDA approved the brand-name drug Rezdiffra (Resmetirom 80 mg) in March 2024. Today, it retails for about $5,400 per month. If you need this treatment but lack insurance coverage, you face a major financial hurdle.
You do have options. High-quality, regulated alternatives exist. Accessing them is legal and entirely possibl
“patient shouuld not have to choose between financial ruin and life-saving treatment”.
Why the 80 mg Dose Costs So Much
Doctors prescribe the 80 mg dose for adults who weigh under 100 kg (220 lbs). However, the US market currently lacks competition for this drug.
Specialty pharmacies exclusively distribute Rezdiffra. You cannot pick it up at a local corner drugstore. This restricted network keeps prices artificially high for cash-paying patients.
Monthly Treatment Cost Comparison
Estimated out-of-pocket costs for Resmetirom 80mg equivalent
Brand Name (Rezdiffra™)
$5,400+
Estimated monthly out-of-pocket
Recommended
Generic Alternatives (WHO-GMP)
~$300
Includes Resmetirom 80mg equivalentProduced by WHO-GMP certified manufacturers like Everest Pharmaceuticals and Incepta.
*Costs vary by region and specific manufacturer. Data based on average market pricing.
Many patients check their Rezdiffra 80 mg copay card eligibility. They often discover a frustrating reality. If you use Medicare, Medicaid, or other government insurance, you do not qualify for the manufacturer’s savings program. This leaves many people paying full price.
High Quality Generic Alternatives
The global pharmaceutical market offers solutions. In countries like Bangladesh, top pharmaceutical companies manufacture generic resmetirom.
Two well-known options are Resmirom 80 by Everest Pharmaceuticals and Frehepta 80 by Incepta Pharmaceuticals.
These companies follow strict WHO-GMP (Good Manufacturing Practice) standards. This certification means they test their active pharmaceutical ingredients (API) rigorously. They produce safe, exact copies of the drug. The clinical results remain the same, but the cost drops significantly.
How Generic Oncology Helps You
Buying medicine online can feel risky. You need to know your MASH liver medication is genuine and safe.
Generic Oncology solves this problem. We connect you directly to WHO-GMP certified manufacturers. We manage the supply chain carefully to protect the drug’s safety and quality.
We also guide you through the Named Patient Program (NPP). This legal framework allows you to import resmetirom for personal use. We handle the specialty pharmacy logistics and customs clearance for you.
Steps to the Named Patient Program
The Named Patient Program requires strict documentation. This ensures you comply with all health and customs laws. Generic Oncology helps you gather and submit three specific items.
medical_information
NPP Documentation Requirements
Essential documents needed to begin your Named Patient Program access for Resmetirom.
1
prescriptions Prescription
Obtain a valid prescription from your treating physician detailing the need for Resmetirom.
2
badge Patient ID
Provide a copy of your government-issued ID (Passport or Driver’s License) for verification.
3
draft Physician Letter
A letter of medical necessity from your doctor explaining why local options are insufficient.
verified
Medications sourced from WHO-GMP certified manufacturers, including Everest Pharmaceuticals and Incepta.
Once you provide these documents, Generic Oncology takes over. We secure your medication and ship it safely to your door. You can focus on your liver health while we handle the logistics.
—Check your eligibility
